Product DescriptiongoogleSheep anti-Alpha-synuclein Polyclonal Antibody (Unconjugated), suitable for IHC-Frozen, IHC-Paraffin-embedded.
Alternative NamesNon-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
Application(s)IHC-Frozen, IHC-Paraffin-embedded
Antibody HostSheep
Antibody TypePolyclonal
SpecificityImmunihistochemical analysis of human and rat brain indicates a high level of specificity for this antiserum. Specificity was also confirmed by western blot. This antiserum is known to react with human and rat alpha synuclein.
Species ReactivityHuman, Rat
Immunogen DescriptionA synthetic peptide (PQEGILEDMPVDPC) of human alpha synuclein protein (aa: 108-120) conjugated to diphtheria toxoid has been used as the immunogen.
ConjugateUnconjugated
Purity DescriptionAffinity purified and dialysed against PBS. Contains 0.02% sodium azide.
Product DescriptionSheep anti-Alpha-synuclein Polyclonal Antibody (Unconjugated), suitable for IHC-Frozen, IHC-Paraffin-embedded.
Application(s)IHC-Frozen, IHC-Paraffin-embedded
Application DetailsIHC. Recommended to be used at a concentration of 1 µg/mL for immunohistochemistry (Paraffin sections). Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
TargetAlpha-synuclein
SpecificityImmunihistochemical analysis of human and rat brain indicates a high level of specificity for this antiserum. Specificity was also confirmed by western blot. This antiserum is known to react with human and rat alpha synuclein.
Target Host SpeciesHuman
Species ReactivityHuman, Rat
Antibody HostSheep
Antibody TypePolyclonal
Antibody IsotypeIgG
ConjugateUnconjugated
Immunogen DescriptionA synthetic peptide (PQEGILEDMPVDPC) of human alpha synuclein protein (aa: 108-120) conjugated to diphtheria toxoid has been used as the immunogen.
Purity DescriptionAffinity purified and dialysed against PBS. Contains 0.02% sodium azide.
FormatLyophilized
Reconstitution InstructionsSpin vial briefly before opening. Reconstitute in 50 µL sterile-filtered, ultrapure water. Centrifuge to remove any insoluble material.
Storage InstructionsAfter reconstitution keep aliquots at -20°C for a higher stability, and at 2-8°C with an appropriate antibacterial agent. Glycerol (1:1) may be added for an additional stability. Avoid repetitive freeze/thaw cycles.
Batch NumberPlease see item label.
Expiration Date12 months after date of receipt (unopened vial).
Alternative NamesNon-A beta component of AD amyloid; Non-A4 component of amyloid precursor; NACP
Scientific BackgroundAlpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. Alpha synuclein has been associated with several neurodegenerative diseases. A point mutation in the gene coding for the alpha-synuclein protein was the first discovery linking this protein to a rare familial form of Parkinson's disease (PD). Subsequently, other mutations in the alpha-synuclein gene have been identified in familial PD. The aggregated proteinaceous inclusions called Lewy bodies found in PD and cortical Lewy body dementia (LBD) were discovered to be predominantly alpha-synuclein. Aberrant aggregation of alpha-synuclein has been detected in an increasing number of neurodegenerative diseases, collectively known as synucleopathies. Alpha-synuclein exists physiologically in both soluble and membrane-bound states, in unstructured and alpha-helical conformations, respectively. The physiological function of alpha-synuclein appears to require its translocation between these subcellular compartments and interconversion between the 2 conformations. Abnormal processing of alpha-synuclein is predicted to lead to pathological changes in its binding properties and function.
Immunohistochemical staining (paraffin-embedded tissue) of alpha synuclein in human neocortex using sheep polyclonal to human alpha synuclein, catalogue number S-078-50.
Immunofluorescence staining of alpha synuclein in cultured cells using Sheep antibody to alpha synuclein, catalog number S-078-50 and fluorescent-labelled secondary antibody. Image courtesy of Dr Wei-Ping Gai, Flinders University of South Australia.